SEQIRUS UK LIMITED
Location
Founded
2015-05-29
Website
Risk Signals
39 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Offices of Holding Companies, Not Elsewhere Classified, Business Services, Not Elsewhere Classified), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about SEQIRUS UK LIMITED
Live alerts from global media, monitored by Business Radar
2024-06-21 (thecattlesite.com)
Weekly global protein digest - China, HPAI in poultry and cattle, Finland to offer avian flu vaccines to high-risk workers
Analyst Jim Wyckoff reports on global protein news
Read more2024-06-04 (thepharmaletter.com)
CSL Seqirus awarded BARDA flu vaccine contract
CSL Seqirus awarded BARDA flu vaccine contract
Read more2024-06-04 (thepharmaletter.com)
CSL Seqirus awarded BARDA flu vaccine contract
CSL Seqirus awarded BARDA flu vaccine contract
Read more2023-09-26 (pharmatimes.com)
UKHSA reaches vaccine deal with CSL Seqirus
Agreement will provide timely boost to pandemic preparedness against influenza
Read more2023-09-26 (pharmatimes.com)
UKHSA reaches vaccine deal with CSL Seqirus
Agreement will provide timely boost to pandemic preparedness against influenza
Read more2022-12-13 (pharmaceutical-technology.com)
CSL closes mRNA vaccine deal with Arcturus
CSL Seqirus has closed the international partnership and licence agreement with Arcturus Therapeutics for sa-mRNA vaccines.
Read more